With only four million people having been fully or partially vaccinated across the country, the University of Health Sciences (UHS) has started working on protocols to start trials for nasal Covid-19 vaccine.
Talking to Dawn, UHS Vice Chancellor Dr Javed Akram said the university had started developing protocols for the clinical trial of the nasal vaccine.
“The vaccine will be single dose and has been manufactured by the Cansino Biologics whose single dose injectable vaccine is already being used in Pakistan. Nasal vaccines are usually given to children but there will be no age limit for it and it can be administered to both children and adults,” he said.
Read full story here.
